WASHINGTON - Duke University Medical Center researchers have found that a surgical procedure used to treat chronic heartburn appears to not only improve the functioning of transplanted lungs, but also has a positive effect on an untreatable form of chronic rejection in lung transplant recipients. The procedure, known as fundoplication, creates a super-competent sphincter at the point where the esophagus meets the stomach. Surgeons create this sphincter by wrapping the top portion of the stomach around the base of the esophagus, preventing gastric acids, enzymes and other stomach contents from splashing up the esophagus and potentially into the lungs. "Reflux occurs in about one-third of patients with end-stage lung disease, and after lung transplantation, two-thirds of patients will experience reflux," said transplant surgeon R. Duane Davis, M.D., surgical director of Duke's lung transplant program. "Lung transplant patients in our study who received the surgery had an average 24 percent increase in their lung functions." Additionally, the fundoplication surgery seemed to have a positive effect on bronchiolitis obliterans syndrome (BOS), a progressive disorder in which tiny airways known as bronchioles become replaced with fibrous scar tissue. BOS is considered to be the main reason why the five-year survival rate for lung transplant patients is only 40 percent. It is little understood and for that reason, there are no effective treatments, Davis said. Davis presented the results of the Duke study, which was funded by Duke's department of surgery, at the annual meeting of the American Association for Thoracic Surgery. Chronic heartburn, also known as gastroesophageal reflex disease (GERD), occurs when contents of the stomach back up, or reflux, into the esophagus, the tube that allows food to pass from the mouth to the stomach. In some cases, the stomach contents can reflux up the esophagus and into the lungs, a condition known as aspiration. For his analysis, Davis prospectively reviewed the records of 108 Duke lung transplant patients. Of those patients, 70 (65 percent) had documented cases of GERD, and 34 of those went on to receive the fundoplication surgery. Of those receiving the surgery, 21 had signs of BOS, which is rated on a scale of BOS-0 to BOS-3, depending on the seriousness of the damage. BOS-3 is the most advanced stage. Of those 21 patients, 11 showed improvements in their BOS scores, with two improving two grades (from BOS-2 to BOS-0)," Davis said. "It appears that we now have a potential treatment for an untreatable condition that seems to work. What we still need to determine is the timing of the surgery." Davis said that it is seems logical the patients with documented GERD should receive the surgery earlier rather than later. "Earlier detection and treatment may prevent irreversible damage to the transplanted lung caused by the aspiration of gastric contents," he said. While the study showed a clear benefit of the fundoplication surgery for lung transplant patients, what is still not clear is the mechanism by which GERD impacts the BOS, Davis said. One theory is straightforward - the caustic gastric contents actually damage or destroy cells lining the lung, Davis said. Since the process of transplantation severs all nerves, transplant patients do not have the normal cough reflex, so any aspiration materials are not quickly cleared. Also, the tiny hairs known as cilia that line lung passages do not function properly in transplant patients. Another explanation, according to Davis, is that the acid causes cells on the transplanted lungs to slough off, causing more donor materials to be presented to the immune system, causing inflammation. "A more intriguing explanation revolves not so much on how the immune system responds to the transplanted organ itself, but how it responds to some other event," Davis said. "If something, like reflux for example, causes inflammation to occur, the immune cells that respond could create a robust response to the injury, leading to BOS. If there wasn't a trigger like reflux, the immune cells would not respond to the transplanted lung alone." Duke surgeons performed their first lung transplant in 1992. In the ensuing 10 years, the Duke program has become the largest in the country, having performed more of the surgeries than any other program in each of the past two years. Other members of the Duke team included Christine Lau, M.D., W. Steve Eubanks, M.D., Theodore N. Pappas, M.D., Dennis Hadjiladis, M.D., Robert Messier, M.D. and Scott Palmer, M.D.
Note to editors: Dr. R. Duane Davis can be reached at (919) 681-4760 or email@example.com. A photograph of Dr. Davis (shown above) is available at http://dukemednews.duke.edu/gallery/detail.php?id=402.